101: Phase II Trial Evaluating Aprepitant (Ap) for Prevention of Nausea and Vomiting Secondary to High-Dose Cyclophosphamide (Cy) Administered to Patients Undergoing Autologous (A) Peripheral Blood Progenitor Cell (PBPC) Mobilization

✍ Scribed by M.H. Abidi; J. Abrams; R. Ibrahim; L. Ayash; S. Cronin; Z. Al-Khadimi; L. Lum; V. Ratanatharathorne; J. Uberti

• Book ID: 116279929
• Publisher: Elsevier Science
• Year: 2008
• Tongue: English
• Weight: 77 KB
• Volume: 14
• Category: Article
• ISSN: 1083-8791
• DOI: 10.1016/j.bbmt.2007.12.110